Updating Treatment Goals for Schizophrenia.

Glutamatergic drugs for schizophrenia are linked to renewed reasons for revisiting their utility, motivating updated treatment goals for the condition.

• Why it matters: Treatment targets for schizophrenia may need updating as evidence continues to reassess how glutamatergic approaches fit into care.
• What they did: The article reviews research on glutamatergic drugs in schizophrenia, focusing on their potential role in treatment utility.
• The result: The synthesis supports reconsidering schizophrenia treatment goals around glutamatergic options, informing how clinicians might evaluate and update therapeutic priorities.

AI summary of the abstract · may contain errors · not medical advice · read the paper.